Key Takeaways
- • CVC Capital Partners is finalizing an acquisition of International Flavors & Fragrances' (IFF) food ingredients division for approximately $4 billion, positioning the firm to outbid competing private equity groups.
- • IFF's food ingredients unit, which produces sweeteners, emulsifiers, and industrial food production components, experienced a 4% decline in net sales during Q4 2025 ($802 million) before rebounding with 3% year-over-year growth in Q1 2026, signaling early turnaround momentum.
- • The carve-out transaction reflects a broader private equity trend of acquiring underperforming divisions from large multinational corporations, driven by higher interest rates and geopolitical uncertainty constraining traditional leverage-driven returns.
- • Recent comparable carve-outs include Advent's $4.8 billion acquisition of Reckitt's cleaning products division and Clayton Dubilier & Rice's €15.5 billion purchase of Sanofi's consumer medications business in 2024, establishing a robust market precedent for this deal structure.
- • IFF initiated the strategic review and sale process for the food ingredients division last summer following weakening demand for plant-based proteins and alternative protein-based ingredients.
Summary
CVC Capital Partners is advancing toward closing an acquisition of International Flavors & Fragrances' food ingredients division at a valuation near $4 billion, according to sources familiar with the transaction. The Amsterdam-based private capital firm has emerged as the leading bidder in a competitive process that included multiple buyout groups. IFF, a New York-listed global manufacturer of flavors, fragrances, and food ingredients, initiated a formal sale process for the unit last year as part of a broader strategic review announced in summer 2025.
The food ingredients division produces a range of industrial food production inputs including sweeteners, emulsifiers, and flavor compounds used in consumer products such as ice creams and snacks. The unit experienced significant headwinds related to declining demand for plant-based proteins and alternative protein ingredients. Financial performance deteriorated in late 2025, with the division reporting net sales of $802 million in Q4 2025, representing a 4% year-over-year decline. However, the business stabilized in early 2026, delivering 3% net sales growth in Q1 2026, suggesting the turnaround plan is gaining traction and may increase the division's attractiveness under new ownership.
CVC's pursuit of this carve-out exemplifies a widening trend among major private equity firms to acquire underperforming or non-core divisions from large multinational corporations. The strategy addresses structural shifts in private equity returns: elevated interest rate environments and persistent geopolitical uncertainty have reduced the viability of high-leverage acquisition models that historically depended on growth and refinancing flexibility. Recent comparable transactions include Advent International's $4.8 billion acquisition of Reckitt Benckiser's cleaning products division and Clayton Dubilier & Rice's €15.5 billion purchase of Sanofi's consumer medications business completed in 2024. These precedents demonstrate substantial institutional capital appetite for carve-out structures where private equity firms can apply operational improvements and strategic repositioning to unlock value in underperforming divisions within larger corporate portfolios.
The food ingredients division produces a range of industrial food production inputs including sweeteners, emulsifiers, and flavor compounds used in consumer products such as ice creams and snacks. The unit experienced significant headwinds related to declining demand for plant-based proteins and alternative protein ingredients. Financial performance deteriorated in late 2025, with the division reporting net sales of $802 million in Q4 2025, representing a 4% year-over-year decline. However, the business stabilized in early 2026, delivering 3% net sales growth in Q1 2026, suggesting the turnaround plan is gaining traction and may increase the division's attractiveness under new ownership.
CVC's pursuit of this carve-out exemplifies a widening trend among major private equity firms to acquire underperforming or non-core divisions from large multinational corporations. The strategy addresses structural shifts in private equity returns: elevated interest rate environments and persistent geopolitical uncertainty have reduced the viability of high-leverage acquisition models that historically depended on growth and refinancing flexibility. Recent comparable transactions include Advent International's $4.8 billion acquisition of Reckitt Benckiser's cleaning products division and Clayton Dubilier & Rice's €15.5 billion purchase of Sanofi's consumer medications business completed in 2024. These precedents demonstrate substantial institutional capital appetite for carve-out structures where private equity firms can apply operational improvements and strategic repositioning to unlock value in underperforming divisions within larger corporate portfolios.
Go deeper than the headline
Research every firm in this story, track the ones that matter and get the daily briefing — free for 7 days.